. Disruption of the pbhrf gene in PbNK65 parasites. (A) Schematic representation of the strategy used to delete the pbhrf open reading frame in PbNK65 parasites using double-crossover homologous recombination. Red lines represent regions of homology. Successful recombination disrupts the HRF-coding sequence and replaces it with the drug resistance marker hDHFR. (B-D) Specific PCR primers (Table S2) 5 GFP-expressing WT, PbNK65-hrfΔ1, or PbNK65-hrfΔ2 iRBCs, and parasitemia (F) or survival (Kaplan-Meier survival plots: log-rank test; n = 11; P = 0.007; G) was followed over time. Error bars, SEM. Experiments were replicated three times.
. Assessment of leukocyte depletion and role of neutrophils and DCs in the occurrence of splenomegaly. (A and B) In vivo depletion of neutrophils using antineutrophil antibody (B) or normal IgG (A) was assessed by measuring at day 6 p.i. the percentage of residual Ly6G + neutrophils in spleens by FACS analysis. (C and D) Depletion of DCs was performed by injection of diphtheria toxin (DTX; D) or saline (C) into CD11c-DTR-GFP mice, and at day 6 p.i., the percentage of CD11c + cells was determined in spleens by FACS analysis. (E-J) Comparison at day 6 p.i. of splenic indexes and total number of leukocytes in WT and PbNK65-hrfΔ1-infected mice untreated or depleted of neutrophils (E-G) or DCs (H-J). (K) Control of T cell depletion (Fig. 2 G) : protected mice received anti-CD3-depleting antibody 1 d before a challenge with WT parasites followed by two booster injections of anti-CD3 at days 1 and 3 after challenge with PbNK65 WT parasites. T cell depletion efficiency was assessed by FACS analysis using anti-CD4-PE or anti-CD8-APC in blood samples from protected mice that were challenged at day 15 p.i. with PbNK65 WT parasites. Analysis was performed 10 d after challenge. Error bars, SEM. Data are representative of two independent experiments with five to six mice per group. *, P = 0.028; **, P = 0.015; ***, P = 0.009; Mann-Whitney test. CTL, control; FSC, forward side scatter; nb, number. Figure S3 . Identification of immune sera-derived immunoprecipitated proteins. (A-D) P. berghei antigens recognized specifically by IgGs from PbNK65-hrfΔ1-protected mice serum were identified by mass spectrometry. (A) Volcano plot representing results of the immunoprecipitated proteins of PbNK65 parasite extract. This plot is colored such that those points having a fold change <1.5 are shown in gray, points >1.5 are in red, and points <1.5 are in blue. Green and red dots display both large-magnitude fold changes (x axis) as well as high statistical significance (−log10 of p-value, y axis). The dashed black line shows where P = 0.05, with points above the line having P < 0.05 and points below the line having P > 0.05. Statistical analysis was performed on triplicate samples. (B) Selected proteins for futher validation are in green in A, and they are reported in the table. (C and D) Evidence that protected sera actually recognize the green dot, GenBank accession no. AAF13063.1 identified as MSP1 protein was assessed by using a recombinant PbMSP1-33 protein by immunoblotting (C) and by ELI SA (D). Error bars, SEM. Experiments were replicated three times (six mice per group). **, 0.02 < P < 0.028; ***, P = 0.0002; Mann-Whitney test. CTL, control. ApaI-5′UTR-PbHRF-F (a) CGC GGG CCC GCG CAT TAT TAC CGT TGT CA PstI-5′UTR-PbHRF-R CGC CTG CAG GGC TTA TGC AAG TAT CGA ACAA KpnI-3′UTR-PbHRF-F CGC GGT ACC TTG CTA CAT GAC GCA TAA ACC EcoRI-3′UTR-PbHRF-R (a') CGC GAA TTC TGT GAA ATC GAC AAT GTT TTGG HRF5′-F (b) GCG ATA CAA ACA AAT TTA TTC AGC HRF3′-R (c') CGC AAG ATA TCA GAG CTT TTCA hDHFR3′-F (c)
TGT TGT CTC TTC AAT GAT TCA TAA ATA GTT GG hDHFR5′-R (b') TGC TTT GAG GGG TGA GCA TTT AAA GC PbHRF-5′orf-F CCA TTT GGA AAT GCG GAAT PbHRF-3′orf-R TTT TTC TTC AAA TAA ACC ATC TGA Bold letters refer to the oligonucleotide's position in Fig. S1 (A and B) .
